CDCA8 and cutaneous melanoma: Meanwhile, CDCA8 knockdown also inhibits cell proliferation and promotes cell differentiation in colorectal cancer, lung cancer, breast cancer, cutaneous melanoma, and human embryonic stem cells (61–65).